888

CS MEDICA A/S DK -,065

No trades
See on Supercharts
Market capitalization
‪7.05 M‬EUR
‪−1.94 M‬EUR
‪142.76 K‬EUR
Beta (1Y)
0.58

About CS MEDICA A/S


CEO
Lone Henriksen
Headquarters
Copenhagen
Founded
2011
ISIN
DK0061668225
FIGI
BBG01FPF7SD1
CS medica A/S engages in the research and development of medical cannabis. The firm distributes its treatment line and skincare products under the CANNASEN trademark. It operates through GalaxaPharma A/S and CANNORDIC A/S segments. The GalaxaPharma A/S segment distributes operations for marketing and sales direct to consumers, retailers, and e-tail. The CANNORDIC A/S segment research and development, establishing global business contracts, supply of CBD ingredients and production of finished products. global sale, to distributors, including Galaxa Pharma in the Nordic Region. The company was founded by Lone Henriksen and Gitte Lund Henriksen on August 7, 2011 and is headquartered in Copenhagen, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 8G8 is 0.460 EUR — it has increased by 1.32% in the past 24 hours. Watch CS MEDICA A/S DK -,065 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CS MEDICA A/S DK -,065 stocks are traded under the ticker 8G8.
8G8 stock has fallen by −2.95% compared to the previous week, the month change is a −16.97% fall, over the last year CS MEDICA A/S DK -,065 has showed a 34.11% increase.
8G8 reached its all-time high on Jul 30, 2024 with the price of 1.610 EUR, and its all-time low was 0.248 EUR and was reached on Dec 22, 2023. View more price dynamics on 8G8 chart.
See other stocks reaching their highest and lowest prices.
8G8 stock is 1.30% volatile and has beta coefficient of 0.58. Track CS MEDICA A/S DK -,065 stock price on the chart and check out the list of the most volatile stocks — is CS MEDICA A/S DK -,065 there?
Yes, you can track CS MEDICA A/S DK -,065 financials in yearly and quarterly reports right on TradingView.
8G8 net income for the last quarter is ‪−415.15 K‬ EUR, while the quarter before that showed ‪−237.03 K‬ EUR of net income which accounts for −75.15% change. Track more CS MEDICA A/S DK -,065 financial stats to get the full picture.
No, 8G8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8G8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CS MEDICA A/S DK -,065 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CS MEDICA A/S DK -,065 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CS MEDICA A/S DK -,065 stock shows the strong sell signal. See more of CS MEDICA A/S DK -,065 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.